Skip to content

Retrospective clinical study for albumin leakage and survival in hemodialysis and online hemodiafiltration

Retrospective clinical study for albumin leakage and survival in hemodialysis and online hemodiafiltration - Prognosis verification of albumin leakage in HD and OHDF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045112
Enrollment
780
Registered
2022-01-01
Start date
2021-07-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with end-stage renal failure undergoing hemodialysis

Interventions

None listed

Sponsors

Social medical corporation Kawashimakai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients on maintenance hemodialysis or online hemodiafiltration 3 times a week as of July 1, 2017

Exclusion criteria

Exclusion criteria: 1) Under 20 years of age 2) Dialysis conditions (dialysis method, dilution method, substitution volume, membrane material) between April 1, 2017 and June 30, 2017, which are different from those as of July 1, 2017 3) Blood purification methods other than HD or OHDF 4) Dialysis frequency below 3 sessions per week or dialysis time below 3 hour per session 5) Substitution volume of less than 60 L in pre-OHDF and less than 8 L in post-OHDF 6) Pregnant or lactating patients 7) Missing values of covariatesat at the start of the study

Design outcomes

Primary

MeasureTime frame
Comparison of all-cause mortality during 3 yearss for estimated albumin leakage (high vs. low) in HD and OHDF

Secondary

MeasureTime frame
1. Comparison of all-cause mortality during 3 years in groups divided by estimated albumin leakage (high and low) and serum albumin concentration (high and low) in HD and OHDF 2. Direct comparison of HD and OHDF on all-cause mortality during 3 years divided by the same ranges of estimated albumin leakage (less than 2.5g, 2.5g or more and less than 5.0g, 5.0g or more and less than 7.5g) 3. Direct comparison of estimated albumin leakage and the substitution volume in pre-OHDF and post-OHDF on all-cause mortality during 3 years

Countries

Japan

Contacts

Public ContactHiroyuki Michiwaki

Social medical corporation, Kawashimakai, Kawashima hospital Department of Clinical Engineering

michiwaki@khg.or.jp088-631-0110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026